Skip to main content

Table 1 Laboratory findings

From: Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report

Tests

  

Tests

  

White blood cells

9,900

/µl

IgG

1,126

mg/dl

Neutrophil

75.9

%

IgA

195

mg/dl

Basophil

0.5

%

IgM

56

mg/dl

Eosinophil

0.3

%

ANA

 < 40

 

Lymphocyte

19

%

Rheumatoid factor

3.6

IU/ml

Red blood cell

475 × 104

/µl

ACE

13.6

U/L

Hemoglobin

14.7

g/dl

Anti-streptolysin-O

44

IU/ml

Hematocrit

43.4

%

Anti-toxoplasma IgG

 < 3

 

Platelet

234 × 104

/µl

CMV antigen (C7HRP)

negative

 

AST

23

IU/L

RPR

negative

 

ALT

30

IU/L

TPLA

negative

 

LDH

216

IU/L

HBs

negative

 

Glucose

97

mg/dl

HCV

negative

 

Blood urea nitrogen

11.6

mg/dl

HLA-B51

negative

 

Creatinine

0.7

mg/dl

HLA-A26

positive

 

C-reactive protein

0.1

mg/dl

TST

negative

 

sIL-2R

483

U/ml

T-SPOT. TB

negative

 

CH50

58

U/ml

   
  1. AST Aspartate aminotransferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase, sIL-2R Soluble interleukin-2 receptor, CH50 50% hemolytic complement activity, IgG Immunoglobulin G, IgA Immunoglobulin A, IgM Immunoglobulin M, ANA Antinuclear antibody, ACE Angiotensin-converting enzyme, CMV Cytomegalovirus, RPR Rapid Plasma Reagin, TPLA Treponema pallidum latex agglutination, HBs Hepatitis B surface antigen, HCV Hepatitis C virus antibody, HLA Human Leukocyte Antigen, TST Tuberculin skin test